Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 230 clinical trials
featured
A Phase II-R and A Phase III Trial Evaluating Both Erlotinib (Ph II-R) and Chemoradiation (PhIII) as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma

A Phase II-R and A Phase III Trial Evaluating Both Erlotinib (Ph II-R) and Chemoradiation (PhIII) as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma

adenocarcinoma
erlotinib
  • 178 views
  • 24 Nov, 2020
  • 1 location
Sequential Neo-adjuvant Chemotherapy Followed by Capecitabine Vs. Conventional Adjuvant Chemotherapy in Breast Cancer

This study evaluates whether sequential neo-adjuvant chemotherapy plus surgery followed by Capecitabine could achieve additional benefits over traditional postoperative chemotherapy. In the

breast cancer
cancer
carcinoma
renal function
capecitabine
  • 0 views
  • 21 Jan, 2021
  • 1 location
The Randomised Study of Preoperative Radiotherapy With Consolidating Chemotherapy for Unresectable Rectal Cancer

The addition of Oxaliplatin to conventionally fractionated chemoradiation (FULV or capecitabine) is considered as standard in unresectable rectal cancer by the panel of experts. The

chemoradiotherapy
metastasis
oxaliplatin
capecitabine
  • 1 views
  • 07 Nov, 2020
  • 1 location
Circulating Tumour DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II Evaluation

for postoperative circulating tumour DNA with vs. without capecitabine.

  • 0 views
  • 24 Jan, 2021
Bevacizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Metastatic Colorectal Cancer That Cannot Be Removed By Surgery

together with combination chemotherapy with or without capecitabine followed by bevacizumab maintenance therapy in treating patients with metastatic colorectal cancer that cannot be removed by

combination chemotherapy
fluorouracil
metastatic colorectal cancer
leucovorin
calcium
  • 7 views
  • 07 Nov, 2020
  • 1 location
Study of IMMU-132 in HR+/HER2- MBC (TROPICS-02)

This is an open-label, randomized, multicenter Phase 3 study to compare the efficacy and safety of Sacituzumab Govitecan versus TPC in subjects with metastatic or locally recurrent inoperable HR+/HER2- MBC, after failure of at least 2, and no more than 4, prior chemotherapy regimens for metastatic disease.

metastasis
eribulin
cancer chemotherapy
HER2
vinorelbine
  • 66 views
  • 05 Oct, 2020
  • 105 locations
Combination of Capecitabine and Oxaliplatin in Metastatic Nasopharyngeal Carcinoma

Primary: - To evaluate the efficacy of capecitabine in combination with oxaliplatin (XELOX) in terms of overall response rate (based on RECIST criteria) in patients with

wbc count
absolute neutrophil count
metastatic nasopharyngeal carcinoma
nasopharyngeal carcinoma
capecitabine
  • 15 views
  • 07 Nov, 2020
  • 1 location
IMRT-SIB and Capecitabine in Preoperative Rectal Cancer Treatment

fractions concomitant with capecitabine results in an improved pCR rate from 9% (Slovenian trial) to 25%. Secondary objectives are to evaluate pathological down-staging rate, histopathological R0

rectal carcinoma
adenocarcinoma of rectum
adenocarcinoma
renal function
capecitabine
  • 3 views
  • 08 Nov, 2020
  • 1 location
Capecitabine and Temozolomide for Treatment of Recurrent Pituitary Adenomas

This is an open label study to assess the efficacy of capecitabine (CAP) and temozolomide (TMZ) in recurrent pituitary adenomas. There will be a safety run-in of at least three patients to

  • 5 views
  • 31 Dec, 2020
  • 1 location
XELOX+Bevacizumab Followed by Capecitabine+Bevacizumab+Radiotherapy as Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma

The purpose of this study is to determine the pathological complete response rate of addition of bevacizumab to induction therapy (xelox) and concomitant treatment (capecitabine

liver metastases
adenocarcinoma of rectum
adenocarcinoma
renal function
capecitabine
  • 7 views
  • 07 Nov, 2020
  • 1 location